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Abstract
Background: The PLUNC (‘‘Palate, lung, nasal epithelium clone’’) protein is an abundant secretory product of epithelia
present throughout the conducting airways of humans and other mammals, which is evolutionarily related to the lipid
transfer/lipopolysaccharide binding protein (LT/LBP) family. Two members of this family - the bactericidal/permeability
increasing protein (BPI) and the lipopolysaccharide binding protein (LBP) - are innate immune molecules with recognized
roles in sensing and responding to Gram negative bacteria, leading many to propose that PLUNC may play a host defense
role in the human airways.
Methodology/Principal Findings: Based on its marked hydrophobicity, we hypothesized that PLUNC may be an airway
surfactant. We found that purified recombinant human PLUNC greatly enhanced the ability of aqueous solutions to spread on
a hydrophobic surface. Furthermore, we discovered that PLUNC significantly reduced surface tension at the air-liquid interface
in aqueous solutions, indicating novel and biologically relevant surfactant properties. Of note, surface tensions achieved by
adding PLUNC to solutions are very similar to measurements of the surface tension in tracheobronchial secretions from
humans and animal models. Because surfactants of microbial origin can disperse matrix-encased bacterial clusters known as
biofilms [1], we hypothesized that PLUNC may also have anti-biofilm activity. We found that, at a physiologically relevant
concentration, PLUNC inhibited biofilm formation by the airway pathogen Pseudomonas aeruginosa in an in vitro model.
Conclusions/Significance: Our data suggest that the PLUNC protein contributes to the surfactant properties of airway
secretions, and that this activity may interfere with biofilm formation by an airway pathogen.
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Introduction
It was first recognized well over three decades ago that
conducting airway secretions exhibit evidence of surface active
material [2]. However, in contrast with alveolar surfactant [3,4],
an understanding of the nature, origin, and function of conducting
airway surfactant has been elusive. Although it is generally agreed
that the airway surface liquid of the large airways possess
surfactant, as inferred from in vivo surface tension measurements
made in large mammals [5,6,7], investigators have struggled to
identify the factor(s) responsible for this reduction in surface
tension. While upper airway secretions are known to contain a
number of phospholipids associated with alveolar surfactant –
most notably dipalmitoylphosphatidylcholine (DPPC) – the critical
surfactant apoproteins surfactant protein B (SP-B) and surfactant
protein C (SP-C) are absent from this region of the lung [5,8]. This
implies the presence of an analogous protein or proteins in the
upper airways, capable of interacting with surfactant lipids to bring
about surface tension lowering effects.
The volume and composition of the airway surface liquid in the
conducting airways is maintained by the surface and submucosal
gland epithelia, which secrete and absorb liquid and numerous
factors involved in host defense and other processes. The PLUNC
protein (Palate, Lung, Nasal Epithelial Clone; also known as
SPLUNC1, LUNX, NASG or SPURT) is a proposed innate
immune factor of approximately 25 kDa, which is present in
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[11,12,13,14,15] and tracheal aspirates [16]. PLUNC is also
present in secreted material from airway epithelial cultures [9,16].
Immunohistochemical studies reveal strong PLUNC staining
along the respiratory epithelium as well as in the tracheal
submucosal glands [16]. Interestingly, it was recently reported
that secreted PLUNC inhibits sodium transport by the epithelial
sodium channel (ENaC) in air-liquid interface cultures of human
airway epithelia [17], suggesting that PLUNC could play a role in
airway surface liquid volume sensing and regulation.
The PLUNC gene is located within a gene cluster on human
chromosome 20, which encodes at least 9 related PLUNC family
members [18]. The PLUNC proteins are evolutionarily related to
two serum glycoproteins, the phospholipid transfer protein (PLTP)
and the cholesteryl ester transfer protein (CETP), as well as two
innate immune factors, the bactericidal/permeability increasing
protein (BPI) and the lipopolysaccharide binding protein (LBP).
With the exception of CETP, whose gene lies on chromosome 16,
the genes for PLTP, BPI and LBP reside on chromosome 20, near
the 39 end of the PLUNC gene cluster. All four proteins are thought
to be structurally related to the PLUNC family members, based on a
conserved exonic structure as well as computer modeling predictions
[18]. Together with PLTP, CETP, BPI, and LBP, the PLUNC
proteins form a superfamily known as the lipid transfer/lipopoly-
saccharide binding protein (LT/LBP) family, whose members share
the ability to bind a variety of lipid substrates. Of note, BPI and LBP
play well characterized roles in sensing and responding to Gram
negative bacteria, mediated primarily through their ability to bind
the Lipid A region of the bacterial cell wall component
lipopolysaccharide [19]. In addition to lipopolysaccharide binding,
the BPI protein is directly antimicrobial against Gram negative
organisms [20]. Thus, the PLUNC protein’s genomic context and its
structural similarity to BPI and LBP have raised the possibility that
PLUNC may possess a host defense function. However, work to
date has failed to demonstrate potent, broad-spectrum antimicrobial
activity by PLUNC.
Here we report that the PLUNC protein has surfactant activity,
and that this activity may account for the low surface tension of
airway secretions. We also present data to suggest a mechanism by
which PLUNC may contribute to host defense. In vitro experiments
with the opportunistic pathogen P. aeruginosa show that physiological
concentrations of PLUNC inhibit the formation of biofilms, matrix-
encased bacterial clusters implicated in the pathogenesis of many
chronic infections. Biofilms persist in the face of intense immune
responses and antibiotic treatment because physiologic changes
inherent to clustered growth make cells far more resistant to killing
than they are in the free-living (planktonic) state [21,22]. Our results
suggest that PLUNC could help prevent biofilm formation in
human airways. This effect could maintain infecting bacteria in a
susceptible state so they can be eradicated by other host defenses.
Results
Gene profiling studies performed previously indicated that
PLUNC is among the most frequently represented transcripts in
cDNA libraries constructed from human airway epithelia [23],
suggesting that PLUNC protein is abundant in the conducting
airways. To investigate the possible function of the PLUNC
protein, we performed a BLAST analysis of human PLUNC
against the non-redundant protein database at NCBI. This
revealed a significant sequence similarity between PLUNC and
the equine protein latherin (Figure 1), the only PLUNC homolog
Figure 1. Multiple sequence alignment of PLUNC and latherin. Alignment depicts the amino acid sequence of human PLUNC (NP_057667),
aligned with horse latherin (NP_001075328). The mature form of PLUNC was predicted using the SignalP 3.0 server (http://www.cbs.dtu.dk/services/
SignalP/) to identify the likely location of the signal sequence [56]. Hydrophobic residues are shown in black, hydrophilic residues are green, basic
residues are blue, and acidic residues are red. Blue boxes indicate conserved residues. Alignment was constructed using the CLC Bio Workbench 4.1.1
(CLC Bio A/S, Aarhus, Denmark).
doi:10.1371/journal.pone.0009098.g001
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isolated from horse sweat, and subsequently shown to display
significant surface activity in a battery of in vitro assays [24,25,26].
On this basis, it was proposed that latherin is a surfactant protein.
Like latherin, PLUNC is notably hydrophobic, with total
hydrophobic residues making up approximately 44.7% of its
amino acid sequence (Table 1). This is comparable to the
observed overall hydrophobicity for latherin of 44.2%. For both
PLUNC and latherin, this marked hydrophobicity is due in part to
an extreme enrichment in the amino acid leucine, which makes up
23.2% of the total residues in PLUNC and 23.6% in latherin [26].
As shown in Table 1, latherin actually shares the greatest amino
acid sequence identity with another member of the human
PLUNC family, the breast cancer and salivary gland-expressed
protein, or BASE, whose gene is the likely ortholog of latherin in
the human genome [27]. However, due to a frameshift mutation
in exon 6, it is thought unlikely that this gene codes for a functional
protein product, and BASE is considered to be a pseudogene. Of
all the human PLUNC family members, PLUNC stands out for its
similarity to latherin in terms of both overall hydrophobicity as
well as leucine content. This characteristic of both latherin and
PLUNC suggests parallels with the well studied pulmonary
surfactant proteins SP-B and SP-C. These proteins, which are
proteolytically processed to give rise to short peptides representing
their active forms, display overall hydrophobicities of 60.8% and
77.1% respectively (Table 1).
Given this sequence similarity, we hypothesized that PLUNC is
an airway surfactant. To test this idea, we first expressed
recombinant PLUNC protein in E. coli, as a fusion protein
containing a cleavable N-terminal maltose binding protein (MBP)
tag as well as a C-terminal 6xHis tag for purification. The MBP
tag served to increase solubility of the markedly hydrophobic
PLUNC protein, as well as to provide an epitope that could be
utilized for purification of the recombinant protein. As shown in
Lane 6 of Figure 2A, we obtained full-length PLUNC at the
expected size of approximately 26 kDa on a reducing SDS-PAGE
gel, estimated to be $95% pure. The identity of this recombinant
protein as PLUNC was verified by N-terminal sequencing and
molecular weight determination using matrix assisted laser
desorption/ionization - time of flight mass spectroscopy
(MALDI-TOF) (not shown), as well as by immunoblotting with
a polyclonal PLUNC antibody (Figure 2B). In keeping with the
noted abundance of PLUNC transcripts in airway epithelial
cDNA libraries, immunoblotting confirmed that human airway
epithelial apical secretions are rich in PLUNC protein
(Figure 2B); based on these and other immunoblotting studies,
we estimate that native PLUNC protein is present in airway
epithelial secretions at concentrations of approximately 10–
250 mg/mL. We observed that recombinant PLUNC migrates
very similarly to native PLUNC protein during SDS-PAGE.
Circular dichroism was used to investigate secondary structure
of this recombinant PLUNC protein (Figure 3). The circular
dichroism signal was negative in the 200–240 nm range, with dips
around 208 and 222 nm indicating presence of secondary
structure with some degree of alpha helicity. Analysis of the
circular dichroism data using the K2d CD secondary structure
server (http://www.embl-heidelberg.de/,andrade/k2d.html)
[28] resulted in a prediction of 24–33% alpha-helical, about
15% beta-sheet and 51–61% random coil structure for PLUNC.
In comparison, the N-terminal region of BPI, to which PLUNC is
believed to be similar [18], is 27% alpha-helical, 46% beta-sheet
and 27% random coil, while its C-terminal region (residues 250–
456) is 24% alpha-helical, 44% beta-sheet and 32% random coil.
To test PLUNC for surfactant activity, we first assessed the
effects of this material on the surface activity of fluids at solid-liquid
interfaces. As shown in Figure 4, we measured advancing contact
angles for drops of various solutions on two types of surfaces.
Samples were first studied on a hydrophobic surface (siliconized
glass) (Figure 4A). In these experiments, the buffer control
(20 mM Tris, 50 mM NaCl, pH 7.3) exhibited a mean contact
angle of 101.5u60.9. In contrast, a solution containing purified
recombinant PLUNC at 150 mg/mL (the highest concentration
tested) produced a statistically significant reduction of the contact
angle to 86.4u60.7, an effect that was diminished as the PLUNC
concentration decreased. Contact angles observed for the control
proteins BSA and MBP (both at the relatively high concentration
Table 1. Comparison of hydrophobicity between latherin and human PLUNC family members.
Protein
Length of mature
protein (No. of residues)
Identity with
latherin (%)
Total hydrophobic
residues (%)
Leucine
composition (%) GRAVY
Latherin 208 – 44.2 23.6 0.330
hBASE 159 39 40.3 15.7 0.040
hPLUNC 237 28 44.7 23.2 0.563
hSPLUNC2 231 22 41.6 16.0 0.113
hSPLUNC3 233 22 38.2 9.9 20.308
BPI 455 N/D 39.1 10.3 20.075
LBP 456 N/D 40.4 13.8 20.002
SP-B 79 N/A 60.8 17.7 1.027
SP-C 35 N/A 77.1 20.0 2.466
Amino acid sequences were obtained for horse latherin (NP_001075328) as well as the human LT/LBP family members BASE (AAO17728.1), PLUNC (also known as
SPLUNC1) (NP_057667), SPLUNC2 (NP_542141), SPLUNC3 (NP_848561.2), BPI (NP_001716.2), and LBP (NP_004130.2). The analyses for SP-B and SP-C were based on the
mature, proteolytically processed peptides for each, as described in [57]. To determine percent sequence identity with latherin, protein-protein BLAST (bl2seq) was
performed to align latherin with each of the short PLUNC family members; for BPI and LBP, the sequence homology with latherin was so low that alignments could not
be made (not done = ‘‘ND’’). For the calculation of percent total hydrophobic residues, the amino acids isoleucine, valine, leucine, phenylalanine, cysteine, methionine,
and alanine were considered to be the hydrophobic residues, based on the hydropathy index developed by Kyte and Doolittle [58]. The GRAVY (grand average of
hydropathicity) value represents the sum of the hydropathy values for each amino acid in a protein, divided by the total number of residues. A protein with calculated
GRAVY .0 is hydrophobic, while a GRAVY ,0 indicates a hydrophilic protein.
doi:10.1371/journal.pone.0009098.t001
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the effects observed for PLUNC were relatively potent and specific
to that protein.
In these studies, ‘‘non-wetting’’ (i.e., non-spreading) solutions,
such as buffer, exhibited advancing contact angles of greater than
90u, while ‘‘wetting’’ solutions (such as Infasurf, a commercial
pulmonary surfactant preparation extracted from bovine lung,
containing surface active lipids and proteins) produced contact
angles of less than 90u. Importantly, the presence of PLUNC in an
aqueous solution appeared to cause contact angles to shift below
this critical 90u angle, with PLUNC-containing solutions shifting
from non-wetting to wetting behavior at concentrations between 5
and 10 mg/mL. The effects of PLUNC on surface spreading were
particularly apparent in time course studies. As depicted in
Figure 4A (inset), a drop of Tris buffered solution dispensed onto
a hydrophobic surface exhibited very little surface spreading over a
45 minute time course, with some loss of volume due to
evaporation. In contrast, a drop of a PLUNC-containing solution
displayed nearly complete spreading over the same time period.
When solutions were dispensed onto a hydrophilic surface (glass)
(Figure 4B), all solutions were observed to spread over the glass
surface (as evidenced by contact angles of less than 90u). However,
at PLUNC concentrations greater than 5 mg/mL, contact angles
were increased with respect to the buffer control, suggesting that
PLUNC at these concentrations interfered with the spreading
behavior of the aqueous solutions. Below this 5 mg/mL concen-
tration, the presence of PLUNC protein appeared to enhance the
wetting ability of the solution.
We next used a pulsating bubble surfactometer to measure the
effects of PLUNC on surface tension at an air-liquid interface
(summarized in Figure 5). We observed that PLUNC significantly
and rapidly reduced the minimum surface tension of a Tris-
buffered solution, to a value of approximately 18 mN/m. This
effect was dose-dependent, with concentrations of only 5 mg/mL
to 10 mg/mL required to observe maximal effects. Minimum
surface tension could not be decreased beyond this value, no
matter how much the PLUNC concentration was increased. As a
positive control we also tested the effects of Infasurf, which
contains a mixture of lipids and the surfactant proteins SP-B and
SP-C. After 3–4 minutes of pulsation, minimum surface tensions of
Infasurf preparations reached approximately 3 mN/m, consistent
with potent surfactant activity.
Interestingly, we found that the PLUNC relatives BPI and LBP
had no significant effects on minimum surface tension even at
concentrations as high as 1 mg/mL, suggesting that surface
tension reduction is not a general property of all LT/LBP family
members and is instead unique to the PLUNC protein. Similarly,
we observed that highly concentrated solutions of BSA (5 mg/mL
and 10 mg/mL) had only very modest effects on minimum surface
tension. As the concentration of BSA used in these studies was
orders of magnitude greater than the tested PLUNC concentra-
tions, this strongly argues for a potent and specific surfactant
activity by the PLUNC protein. We also examined the interaction
Figure 2. Expression and purification of recombinant human PLUNC. (A) Recombinant PLUNC protein was expressed in E. coli as described
in the Methods. After centrifugation, the crude bacterial lysate (Lane 1) was passed over amylose resin and bound fusion protein was eluted from the
resin using maltose. The recovered elution fraction (Lane 2) indicated a predominant product of approximately 69 kDa on a reducing SDS-PAGE gel,
consistent with the predicted size of the MBP-PLUNC-6xHis fusion protein. Fusion protein was further purified by gel filtration, followed by a 16 hour
cleavage with Factor Xa protease to remove the MBP tag. Factor Xa treatment gave rise to two cleavage products, MBP at 43 kDa and PLUNC-6xHis at
approximately 26 kDa (Lane 3). After passing the cleavage products over nickel resin, MBP was observed in the flowthrough fraction (Lane 4), while
the elution fractions contained PLUNC-6xHis and any remaining uncleaved His-tagged fusion protein (Lane 5). A final gel filtration step was used to
separate PLUNC-6xHis from the uncleaved protein (Lane 6). Cleaved PLUNC-6xHis, in its final form, is indicated by the arrow. MW = molecular weight
ladder (BenchMark Unstained Protein Standard; BioRad) (B) Representative immunoblot, in which increasing concentrations of purified recombinant
PLUNC-6xHis were electrophoresed and probed using a monoclonal antibody directed against the human PLUNC protein, revealing a single
immunoreactive band at the expected molecular weight in the range of 20–25 kDa. Immunoblotting also demonstrated the presence of native
PLUNC protein in apical secretions from primary cultures of well-differentiated human bronchial epithelia (BE) and nasal epithelia (NE). See Methods
for details.
doi:10.1371/journal.pone.0009098.g002
Figure 3. Circular dichroism spectra of recombinant human
PLUNC. Circular dichroism spectra of recombinant human PLUNC.
Molar ellipticities in the far-UV range (197–260 nm) are plotted for
PLUNC at 0.54 mg/mL (circles), 1.08 mg/mL (triangles), and 2.16 mg/mL
(boxes). Analysis of this data using the K2d server predicts that the
secondary structure of PLUNC is 24-33% alpha-helical, ,15% beta-sheet
and 51–61% random coil.
doi:10.1371/journal.pone.0009098.g003
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the sessile drop technique for various solutions dispensed onto siliconized glass, a hydrophobic surface. Bars depict the mean values for contact
angles (in degrees) measured one minute after drops were dispensed onto the solid surface. Error bars represent the standard error about the mean
(n=6). Contact angles (h) of less than 90u (dotted line in panel A) indicate wetting of the surface by the drop, whereas contact angles greater than 90u
(to the right of the vertical line) indicate that a sample is ‘‘non-wetting’’. The solid vertical line separates the solutions that have greater wetting ability
than buffer alone (bars pointing left) from the ones that have lesser wetting ability (bars pointing right). Asterisks denote measurements that are
significantly different from buffer, as determined by Student’s two-tailed t-test (P-value ,0.01). On a hydrophobic surface, PLUNC solutions
transitioned from ‘‘non-wetting’’ to ‘‘wetting’’ at concentrations greater than 10 mg/mL. Inset: spreading behavior over time was compared for Tris
buffer and a PLUNC-containing solution dispensed onto a hydrophobic surface. On each coverslip, the drop on the left is buffer, while drops of
PLUNC (140 mg/mL) are shown on the right. Drop spreading was photographed after 5 minutes, 25 minutes, and 45 minutes, revealing that the
presence of PLUNC conferred an increased tendency for an aqueous solution to spread on a hydrophobic surface. In panel (B), drops of test solutions
were formed on unmodified glass, a hydrophilic surface, and advancing contact angles were measured as described above. On a hydrophilic surface,
PLUNC enhanced wetting when at lower concentrations (1–2 mg/mL), while higher PLUNC concentrations (5–150 mg/mL) appeared to reduce
wetting ability. Infasurf, a commercial lung surfactant, displayed significant wetting ability on both hydrophilic and hydrophobic surfaces.
doi:10.1371/journal.pone.0009098.g004
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a well documented role in inhibiting pulmonary surfactant
components [29]. In mixtures of PLUNC and BSA, BSA effects
appeared to dominate early on in the surfactometer experiments,
but these effects were always eventually overcome by the surface
tension lowering activities of PLUNC (Figure 6). This pattern
suggests that PLUNC effectively competes with BSA for space at
the air-liquid interface.
A final parameter that was considered in the surfactometer
studies was the range, in other words, the difference between
maximum and minimum surface tension that was observed for
each test solution during cycling. An effective biological surfactant
will exhibit a large range, reflecting an ability to rapidly adjust
surface tension throughout pulsation, while a poor surfactant will
exhibit a relatively small range. As shown in Figure 5, not only
did PLUNC display dose dependent surface tension lowering
activity, but it exhibited ranges that were more similar to that for
the known surfactant Infasurf than to those observed for control
proteins including BSA and MBP.
The potency of the PLUNC protein’s surface active properties
raised the possibility that its surfactant activity may mediate its
biological function in the airways. A clue to a potential function
was suggested by work investigating mechanisms of biofilm
detachment. Detachment is the process by which bacteria separate
from biofilm clusters and return to the free-living (planktonic)
state. In one established detachment mechanism, bacteria secrete
surfactants that disrupt the biofilm structure, enabling individual
bacteria to escape [1,30]. These data, coupled with our finding
that PLUNC has surfactant properties, led us to hypothesize that
PLUNC might have anti-biofilm activity.
We tested this hypothesis using the opportunistic pathogen
Pseudomonas aeruginosa, a model organism for biofilm research. P.
Figure 5. Reduction of surface tension at an air-liquid interface by PLUNC protein. The pulsating bubble surfactometer was used to
measure dynamic surface tension in solutions containing increasing concentrations of recombinant PLUNC, as described in Methods. For each
sample, the minimum surface achieved at 5 minutes of pulsation is shown as a gray bar. The range, representing the difference between the
minimum and maximum surface tensions at the 5 minute time point, is depicted in white. Error bars, where present, represent the standard error
about the mean (n=3 experiments).
doi:10.1371/journal.pone.0009098.g005
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cystic fibrosis and bronchiectasis. Furthermore, the biofilm growth
mode has been implicated in the pathogenesis of these and other
chronic infections. Compared to the untreated and vehicle controls,
PLUNC treatment interfered with biofilm growth at the air-liquid
interface of static cultures. After 72 hours of growth, cultures treated
with 100 mg/mL of PLUNC accumulated less biofilm biomass as
assayed by visual inspection of crystal-violet stained biofilms
(Figure 7A), and by measuring the amount of stain retained after
repeated cycles of washing (Figure 7B). Similar results were
obtained using 50 and 25 mg/mL of PLUNC (data not shown). In
cultures grown with PLUNC, we also observed that biomass
periodically separated from the biofilm and sank to the bottom of
the culture tubes (Figure 7C and D). In contrast, biofilms that
grew in control media remained as tight aggregates for the duration
of the experiments (72 hours). The anti-biofilm effect of PLUNC
was not due to bacterial growth inhibition, as PLUNC had no effect
on P. aeruginosa growth [31]. These data show that PLUNC inhibits
model P. aeruginosa biofilms in vitro, and suggest that it may contribute
to anti-biofilm defenses in vivo.
Discussion
Here, we describe for the first time a novel surface tension
lowering activity for the PLUNC protein, a finding which may
provide insight into whether and how PLUNC participates in host
defense. Most PLUNC studies to date have focused on its
proposed role as a host defense molecule, based largely on its weak
primary sequence similarity to BPI and LBP. Given the noted
abundance of the PLUNC protein in the nasal, oral and tracheal
regions, it is often suggested that this protein may represent an
innate immune molecule with properties uniquely suited to the
milieu of the upper airways [18,32,33]. This is supported by the
observation that PLUNC orthologs have thus far only been
identified in the genomes of air-breathing mammals [27].
However, while it is often hypothesized that PLUNC acts as a
directly antimicrobial protein, evidence for this is limited. Notably,
PLUNC lacks the characteristic cationic charge density seen in
Figure 6. PLUNC interaction with albumin in the pulsating
bubble surfactometer. The pulsating bubble surfactometer was used
to measure dynamic surface tension in solutions containing mixtures of
PLUNC and bovine serum albumin (BSA). Plotted values represent
surface tension minima over time for Tris buffer (NNNN), BSA at 10 mg/mL
(----), PLUNC at 10 mg/mL (__ ) or PLUNC (10 mg/mL) with BSA (10 mg/
mL) (—). In the presence of BSA, it takes longer for PLUNC to reach its
saturation value for minimum surface tension.
doi:10.1371/journal.pone.0009098.g006
Figure 7. PLUNC inhibits biofilms growing at the air-surface
interface. (A) Crystal violet staining of P. aeruginosa PA14 biofilms
shows that PLUNC (100 mg/mL) reduced the biofilm biomass accumu-
lating on the sides of culture tubes after 72 hours of growth. (B) The
amount of crystal violet retained by biofilms was quantitated using
optical density measurements. Growth of PLUNC-treated biofilms (n=3)
was significantly inhibited compared to non-treated and buffer-treated
biofilms. Error bars show standard deviation. * P,0.025. (C) Biofilms
formed at the air-liquid interface of unshaken cultures after 48 hours of
growth. (D) Magnification of areas outlined in panel C shows that in
media containing 100 mg/mL PLUNC, biomass spontaneously separates
from the air-liquid interface biofilm and sinks toward the bottom of the
culture tube.
doi:10.1371/journal.pone.0009098.g007
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Bartlett et al. found no killing activity against Escherichia coli,
Pseudomonas aeruginosa,o rListeria monocytogenes [31], while Chu and
colleagues reported that recombinant murine PLUNC inhibited
growth of Mycoplasma pneumoniae but inhibited E.coli only minimally
(,15%) [34]. The lack of broad spectrum bactericidal activity
suggests that PLUNC may target particular microorganisms, or
that it contributes to host defense in unconventional ways. As
discussed below, our findings indicate that one function of
PLUNC may be to prevent chronic infections by inhibiting the
formation of resistant bacterial biofilms.
The recognition that PLUNC is markedly hydrophobic, a
property that it shares with the known surfactant protein and
PLUNC family member latherin, initially led us to wonder
whether PLUNC might have unusual effects on the behavior of
aqueous solutions. We noted that the PLUNC protein is found in
vivo in locations involving air-liquid interfaces, sites at which
surface tension effects could be particularly relevant. Our contact
angle analysis demonstrates that recombinant PLUNC signifi-
cantly reduces the advancing contact angle observed for drops of
aqueous solution on a hydrophobic surface, from 101.5u60.9 for
buffer alone to values between 80u and 90u for PLUNC at
concentrations above 10 mg/mL. These results are comparable to
those for latherin, which was observed to reduce the contact angle
of a Tris-buffered solution to 8661u at a concentration of 1 mg/
mL (a nearly 10-fold higher concentration than the PLUNC
concentrations used in our studies) [24]. These observations were
further supported by pulsating bubble surfactometer experiments,
which indicated that PLUNC reduces the surface tension of a Tris-
buffered solution to as low as 18 mN/m. In terms of effectiveness
as a surfactant, this places PLUNC somewhere between the
activity that would be observed for a random, non-surfactant
protein such as BSA - which has no or only a very modest effect on
surface tension even at high concentrations - and Infasurf, a
complex mixture of lipids and surfactant proteins (in particular,
SP-B and SP-C) that can achieve surface tensions approaching
0 mN/m. Of note, SP-B and SP-C in their active forms exhibit a
greater degree of hydrophobicity than do latherin and PLUNC
(Table 1), which may explain in part the greater surface tension
reducing potency of pulmonary surfactant compared to PLUNC
in solution.
These surface tension effects were observed for PLUNC protein
in the concentration range of 5 to 50 mg/mL. The concentration
of PLUNC protein in airway surface liquid in vivo has not been
clearly defined, although it is estimated that PLUNC makes up
approximately 1% of the total protein in human nasal lavage fluid
[15], and as much as 10% of the total protein in secretions from
air-liquid interface cultures of human tracheobronchial epithelia
[16]. As described in Figure 2, our studies suggest that PLUNC is
present in airway surface liquid from well-differentiated human
airway epithelia at a concentration of 10–250 mg/mL. Thus, we
believe that these surface tension reducing effects by PLUNC
occur in a concentration range that is physiologically relevant.
Several lines of evidence indicate that the conducting airways
contain an agent or agents with surface activity. Measured surface
tensions in upper airway fluids are significantly lower than would
be expected in the absence of a surfactant. In vivo measurements of
airway surface fluid lining the sheep bronchus indicate that surface
tension in this region of the respiratory tract is 3262 mN/m [7],
while similar methods produced a surface tension of 31.960.5 for
horse trachea [6]. In another study, surface tension was measured
in porcine tracheal aspirates using a pulsating bubble surfact-
ometer. In agreement with the in vivo findings, these tracheal
aspirates exhibited minimum surface tensions in the range of 20–
30 mN/m [5]. Similarly, Tarran and colleagues reported a surface
tension of 33.960.6 mN/m for airway surface liquid at the apical
surface of air-liquid interface cultures of human airway epithelia
[35]. In contrast, the surface tension of pure water is 72 mN/m
[36].
While it is generally believed that surfactant is present in the
conducting airways, the nature and origin of this layer is not well
characterized. Bernhard et al. [5] observed that surfactant extracts
from porcine tracheal aspirates display a phospholipid composi-
tion similar to that recovered from bronchoalveolar lavage (BAL)
fluid, suggesting an alveolar origin for these tracheal phospholip-
ids. In this study, despite similar phospholipid compositions,
surfactant extracted from tracheal aspirates exhibited a modest
reduction in its surface activity with respect to BAL-derived
surfactant. This raises the possibility that variable protein content
might account for differences in surface activities between
surfactant preparations derived from different regions of the lung.
Interestingly, while surfactant extracted from tracheal aspirates
was shown to be more proteinaceous overall than BAL-derived
surfactant, this material exhibited significantly reduced levels of
the pulmonary surfactant protein SP-A [5]. Furthermore, the
hydrophobic surfactant proteins SP-B and SP-C were undetect-
able in surfactant of tracheal origin. These observations suggest
that surfactant function in the conducting airways may involve
additional proteins, which have yet to be defined.
We propose that PLUNC is one such protein. This is supported
by the observation that purified recombinant PLUNC protein
produces minimum surface tensions in a range that is consistent
with observed in vivo surface tensions measured in the conducting
airways of several species [5,6,7,35]. Additionally, PLUNC
belongs to a family of proteins whose common characteristic is
the ability to bind lipids, suggesting that PLUNC may interact
with lipids as well [18]. However, we emphasize that our contact
angle and pulsating bubble surfactometer studies demonstrating
surface active properties for PLUNC were all performed in the
absence of any added lipids, suggesting that lipids are not
necessary for PLUNC to exert its effects. PLUNC appears to
possess surfactant-like properties on its own, in the absence of
added lipids; in contrast, SP-B and SP-C reduce surface tension
through their effects on the packing and compression of
phospholipid layers. Thus, PLUNC may not be truly analogous
to SP-B and SP-C. This question should be resolved by further
investigation of lipid-binding activities by PLUNC. The broader
question - determining the relative contribution of PLUNC
protein to the overall surface tension of airway surface liquid in
the upper airways - will require more in-depth studies involving
genetic gain or loss of function approaches.
What purpose might surfactant serve in the large airways? In
the distal lung, surfactant is critical to prevent the collapse of
alveoli and the narrow passageways of the terminal bronchioles
upon expiration [3]. However, the patency of the larger airways is
maintained by elastic and cartilaginous support, so surfactant is
unlikely to be critical in this region. It has been suggested that an
airway surfactant may play a role related to lubrication; in support
of this, there is evidence that surfactants can enhance rates of
mucociliary transport [37,38] and ciliary beat frequency [39].
Another possibility is offered by Schu ¨rch and colleagues, who
suggest that low surface tension in airway secretions aids in the
immersion of foreign particles into the airway surface liquid layer
[7,40]. Thus, it is possible that one role of PLUNC in the airways
is to reduce surface tension to levels that enable immersion of
inhaled bacteria and other particles into the airway surface liquid
layer, facilitating their uptake by macrophages or elimination by
other components of the innate immune system.
PLUNC Is a Surfactant Protein
PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9098Our data suggest that the surfactant activity of PLUNC may
provide protection against chronic infections by inhibiting the
formation of bacterial biofilms. Conventional host defenses
prevent infection by killing bacteria, inhibiting their growth, or
facilitating their expulsion from sterile sites. Sometimes, however,
bacteria escape initial killing. For example, during infections such
as bronchitis, acute sinusitis, conjunctivitis, or infections associated
with foreign bodies, bacteria can persist on mucosal surfaces for
prolonged periods. If these bacteria form biofilms, immune
responses, including those mediated by recruited phagocytes and
adaptive immunity, are unlikely to be effective [22]. Host defenses
that prevent biofilm formation could keep surviving bacteria in a
susceptible state until robust immune responses are generated.
Precedents exist for anti-biofilm host defenses on mucosal
surfaces. The protein lactoferrin, which is highly abundant in
mucosal secretions (including airway secretions), has been shown
to prevent biofilm formation by P. aeruginosa at concentrations
below those that killed or prevented bacterial growth [41]. The
iron-chelating activity of lactoferrin stimulates twitching, a
specialized form of surface motility. This causes bacteria to
wander over surfaces instead of forming cell clusters and biofilms
[41]. The cationic host defense peptide LL-37 has also recently
been shown to have specific anti-biofilm effects at concentrations
below those that inhibited growth [42]. Our findings suggest that
PLUNC may have similar effects, and raise the possibility that
multiple anti-biofilm host defenses may exist. As is the case for
antimicrobial factors that kill or inhibit bacterial growth, the
presence of multiple factors could provide synergistic or redundant
activity [43]. This could increase potency, widen the spectrum of
organisms targeted, and perhaps prevent the emergence of strains
resistant to anti-biofilm defenses.
The possibility that a host-derived surfactant disrupts biofilm
formation is interesting in light of previous work showing similar
activity of surfactants of microbial origin. As noted above, biofilm-
forming organisms possess active mechanisms that allow them to
leave biofilms and return to the planktonic state. Interestingly, P.
aeruginosa uses the self-produced surfactant, rhamnolipid, to bring
about biofilm detachment [1,44] and rhamnolipids can also
disrupt biofilms formed by Bordetella bronchiseptica [45]. Further-
more, Pseudomonas putida uses biosurfactants (Putisolvin I and II) for
the same purpose [44], and surfactants can disrupt Salmonella
typhimurium biofilms [46]. Recently, surfactants produced by
Lactobacillus acidophilus were shown to inhibit Staphylococcus aureus
and Staphylococcus epidermidis biofilms [47], raising the possibility
that a surfactant-mediated anti-biofilm activity could be respon-
sible for the probiotic effects of Lactobacillus species. Taken
together, these findings suggest that surfactants may have broad
spectrum anti-biofilm activity.
The notable surface active properties of PLUNC suggest that
the molecule orients itself in a monolayer at the air-liquid
interface, with the hydrophobic face of the molecule facing the
air and hydrophilic regions in contact with the solution. Such a
property is characteristic of surfactants. Although we currently
have no structural data to formally demonstrate that PLUNC
adopts such an amphipathic structure, we presume that such a
phenomenon occurs. While the exact mechanism by which
surfactants disrupt biofilms is not known, the presence of both
hydrophobic and hydrophilic moieties may allow them to
concentrate at physical interfaces and disrupt prevailing interac-
tions [48]. This could dislocate surface adhesins that tether
bacteria to each other, or to the biofilm matrix. Previous work
shows that rhamnolipids can cause the release of LPS from P.
aeruginosa [49] and they may have similar effects on other surface
appendages. Another possibility is that surfactants disrupt and
solubilize key matrix components, perhaps even incorporating
them into micelles. The ability of surfactants to promote bacterial
motility and alter cell surface charge [50,51] could also help to
release bacteria from biofilms. Whatever the mechanism, the anti-
biofilm defense provided by PLUNC and other airway proteins
could provide a fail-safe mechanism that prevents bacteria that
survive initial defenses from assuming the intractable biofilm state.
This activity could help explain the remarkable resistance of
healthy mucosal surfaces to chronic infections.
In summary, we present evidence that PLUNC possesses
surfactant-like properties, indicating that this protein plays a role
in lowering surface tension in the upper airways. Furthermore, we
show that PLUNC inhibits the formation of P. aeruginosa biofilms in
vitro, suggesting that one biological function of the PLUNC protein
may be to prevent chronic infections on mucosal surfaces. As such,
these studies have revealed a novel and unexpected mechanism by
which the PLUNC protein may participate in innate immunity in
the conducting airways. Future work will be required to explore
whether PLUNC inhibits biofilms formed by other bacterial
species and to assess its overall contribution to host defense in vivo.
Materials and Methods
Ethics Statement
This study involved the use of human lung and nasal tissues
obtained with written donor consent. Culture of human airway
epithelia was carried out using methods approved by the
Institutional Review Board of the University of Iowa.
Expression and Purification of Recombinant PLUNC
The cDNA for human PLUNC (NCBI accession number
NM_016583) was cloned into the plasmid vector pMAL-c2x (New
England Biolabs). Full-length fusion protein, containing a
cleavable N-terminal maltose binding protein (MBP) tag and a
C-terminal 6xHis tag, was expressed in the E. coli strain BL21 Star
(DE3) (Invitrogen Corp, Carlsbad, CA) and the protein purified by
passing over amylose resin (New England Biolabs Inc., Ipswich,
MA). MBP-tagged fusion protein was eluted from the amylose
resin using Tris buffer (20 mM Tris, 50 mM NaCl, 0.001%
Tween-20, pH 7.3) containing 10 mM maltose. Eluted fusion
protein was concentrated to approximately 2 mg/mL under
nitrogen pressure (40–50 psi) with stirring, using an Amicon
Ultrafiltration membrane (30,000 MWCO; Millipore, Billerica,
MA). Protein was then further resolved by passage through a
Superdex 75 gel filtration column (Amersham; GE Healthcare,
Pittsburg, PA). The resulting chromatogram indicated the
presence of two peaks, corresponding to two distinct populations
of recovered fusion protein. Both populations contained MBP-
PLUNC-6xHis (confirmed by Coomassie staining of the fractions
on SDS-PAGE gels); however, the higher molecular weight
portion (represented by the first peak) appeared to be resistant to
cleavage by Factor Xa protease (New England Biolabs, Inc.,
Ipswich, MA). Fractions corresponding to the second peak were
pooled and concentrated to approximately 1 mg/mL using
Amicon Ultra-15 centrifugal filter units (30,000 MWCO; Milli-
pore, Billerica, MA), followed by removal of the MBP tag by
Factor Xa cleavage carried out for approximately 16 hours at 4uC.
The cleavage products were passed over nickel resin (Ni Sepharose
6 Fast Flow; GE Healthcare Biosciences Corp., Piscataway, NJ),
and pure PLUNC-6xHis eluted from the resin using Tris buffer
(20 mM Tris, 50 mM NaCl, pH 7.3) containing 500 mM
imidazole. As a final purification step, the protein was again
passed over a Superdex 75 gel filtration column and fractions
containing pure ($95%) PLUNC-6xHis were pooled and
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MWCO; Millipore, Billerica, MA). After purification of the fusion
protein and cleavage of the MBP tag, we observed a tendency for
the remaining PLUNC product to precipitate; thus, 0.001%
Tween-20 (v/v) was present at most stages in the purification
process to improve the stability of PLUNC in solution. However,
to prevent interference from Tween-20 in ensuing biophysical
analyses of PLUNC, Tween-20 was removed from the buffers at
the final purification step. Throughout the purification procedure,
concentration estimates were calculated using absorbance at
280 nm (extinction coefficient 68,000 M
21 cm
21). Concentration
estimates at the final purification step were obtained using the
Bradford assay (Pierce Biotechnology, Inc., Rockford, IL).
Culture of Human Airway Epithelia
Primary cultures of human airway epithelia were prepared from
nasal tissue and bronchi by enzymatic dispersion using established
methods [52]. Briefly, epithelial cells were dissociated and seeded
onto collagen-coated, semipermeable membranes with a 0.4-mm
pore size (Millicell-HA; surface area, 0.6 cm
2; Millipore Corp.,
Bedford, MA). Cells were maintained in 2% Ultroser G medium at
37uC with 5% CO2. Twenty-four hours after seeding, the mucosal
medium was removed and the cells were allowed to grow at the
air-liquid interface. Only well-differentiated cultures (.2 weeks
old) were used in these studies. The presence of tight junctions was
confirmed by transepithelial resistance using a volt-ohm meter
(World Precision Instruments, Sarasota, Fla.; resistance
.500 V?cm
2).
Immunoblotting
Rabbit polyclonal PLUNC antiserum was generously provided
by Dr. Philip Whitney at the University of Miami School of
Medicine [16]. To collect secretions for immunoblotting experi-
ments, the apical surfaces of polarized human airway epithelia
were rinsed with PBS (containing Mg
2+ and Ca
2+) along with
Complete Mini protease inhibitor (Roche Applied Science,
Indianapolis, IN). Samples were collected in a total volume of
,200 mL per 24-well plate and stored at 4uC until use. For SDS-
PAGE, 22.5 mL of airway epithelial wash was loaded per lane.
Samples were electrophoresed through 4–20% gradient Tris-HCl
gels (BioRad Laboratories, Hercules, CA) and transferred to
nitrocellulose membranes, followed by blocking overnight in TBS-
Tween containing 5% powdered milk. Membranes were incubat-
ed with PLUNC antiserum, diluted 1:1000 in TBS-Tween, for
1.5 hours. Following four 5 minute washes in TBS-Tween,
membranes were probed with horseradish peroxidase (HRP)
conjugated goat anti-rabbit secondary antibody (Sigma-Aldrich,
St. Louis, MO) at 1:20,000 for 1 hour. Another series of 5 TBS-
Tween washes was performed, and bands were detected using
SuperSignal West Pico Chemiluminescent Substrate (Pierce
Biotechnology, Inc., Rockford, IL).
Circular Dichroism
Circular dichroism spectra were recorded for recombinant
PLUNC in the range 197–260 nm using an Aviv 62DS
spectrometer (Aviv Associates Inc., Lakewood, NJ) and a quartz
cuvette of 1 mm path length (Starna Cells, Atascadero, CA).
Spectra were collected 5 times per sample and averaged for 3
different concentrations of PLUNC (0.54 mg/mL, 1.08 mg/mL
and 2.16 mg/mL). Concentrations for the circular dichroism
samples were estimated by Beer-Lambert’s law using absorbance
at 280 nm and a calculated extinction coefficient of 1490 M
21
cm
21. The percentage of secondary structure was calculated by
deconvoluting the circular dichroism spectra using the online K2d
CD secondary structure server, based on an unsupervised neural
network algorithm [28,53].
Contact Angle Measurements
For wettability studies, 3–10 mL drops of solutions containing
PLUNC, control proteins or Infasurf were dispensed onto
Fisherbrand microscope glass cover slides (12-545-10, Thermo-
Fisher Scientific, Pittsburgh, PA) or siliconized glass cover slides
(Hampton Research, Aliso Viejo, CA). Advancing contact angles
were measured by the sessile drop technique at room temperature,
using a Rame ´-Hart NRL 100-00 goniometer (Rame ´-Hart Instru-
ment Co., Mountain Lakes, NJ). For each sample, 3 replicates were
performed, in 2 different spots on the coverslide, for a total of 6
measurements per sample. Contact angle measurements were
collected at 1, 2 and 3 minutes after drop formation. Measurements
for each time point were averaged to obtain the mean contact angle
for each sample, as well as to calculate standard error about the
mean. For all samples, contact angles were observed to decrease
with time, suggesting possible evaporative effects as the experiment
was not done in a controlled humidified chamber. Since the trends
were identical for the samples at any given time point, only the 1
minute measurements are reported.
Pulsating Bubble Surfactometer
Surface tension effects were measured using a pulsating bubble
surfactometer (General Transco, Inc., Largo, FL), originally
described by Enhorning [54]. To measure dynamic surface
tension, a test solution was loaded into a disposable sample
chamber, within which a spherical air bubble was formed that
maintained contact with outside air. The air bubble was pulsated
at a rate of 20 pulses per minute, between a defined minimum
bubble radius of 0.4 mm and a maximum bubble radius of
0.55 mm (representing a 50% surface area change). Changes in
pressure across the bubble interface were recorded and used to
calculate surface tension values throughout cycling according to
the Law of Laplace. For these studies, InfasurfH (Forest
Pharmaceuticals, Inc., St. Louis, MO) was diluted 4-fold prior to
loading into the surfactometer. Bovine serum albumin (BSA) for
these studies was obtained from Sigma-Aldrich (St. Louis, MO)
and maltose-binding protein (MBP) was obtained from New
England Biolabs, Inc. (Ipswich, MA). Recombinant human BPI
and LBP were generously provided by Dr. Jerrold Weiss at the
University of Iowa. All proteins were maintained in a Tris buffer
(20 mM Tris, 50 mM NaCl, pH 7.3), with the exception of BPI
and LBP, which were maintained in HEPES buffer. Data were
collected using the software supplied with the instrument and
transferred to a computer for analysis. The minimum and
maximum surface tension values for each pulsation cycle were
extracted and plotted. To compare all samples simultaneously,
surface tension values after 5 minutes of pulsation were used.
Biofilm Culture Conditions and Growth Quantitation
Biofilms were cultured statically for 72 hours at room
temperature in borosilicate glass (136100 mm) tubes containing
1 mL of Luria-Bertani (LB) broth. Purified PLUNC was added to
LB broth to give a final concentration of 100 mg/mL and a
corresponding volume of buffer was added to LB broth for the
vehicle control. Overnight cultures of P. aeruginosa PA14 were
washed twice with phosphate buffered saline solution, and 30 mL
were used to inoculate biofilms. Biofilm growth was quantified as
previously described [55] except that methanol was used to elute
the crystal violet stain adhering to the biofilm, after washing with
PBS. Crystal violet staining was quantified by measuring the
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